Since the antioxidant enzymes activities are up-regulated following an increase of ROS production in cancer cells, we supposed that the decrease in TrxR1 could result from the low levels of ROS in treated cells (low stimuli of Trx and TrxR1 expression), and not a direct inhibition of the enzyme by FPH. Here, TXNRD1 is linked to cancer.